FdaApplication
ANDA 212602
Identifiers
- fda_app_no: ANDA212602
Properties
| Property | Value |
|---|---|
| applicant_name | INVAGEN PHARMACEUTICALS INC |
| application_type | ANDA |
| approval_date | 2020-04-20 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| COLESEVELAM HYDROCHLORIDE | COLESEVELAM HYDROCHLORIDE | 625MG | TABLET;ORAL |
1 product